Stemcyte India Therapeutics Private Limited - Company Profile

It is a healthcare foreign private limited company based in Ahmedabad, Gujarat, India, established in 2008.
2008 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Stemcyte India Therapeutics Private Limited

Stemcyte India Therapeutics Private Limited, a active foreign private limited company, was established on 08 February 2008 in Ahmedabad, Gujarat, India. Engaging in healthtech & medical tech solutions within the hospital and medical care sector, it holds CIN: U85100GJ2008FTC052859. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.98 M.

It upholds a compliant status. Its leadership includes Chandra Sekhar Chivukula (Director), Amitabha Banerjee (Director), Wise Young (Director). Past directors included Chandra Sekhar Chivukula, Amitabha Banerjee, Rajiv Indravadan Modi. Its latest AGM occurred on 28 August 2025, with the balance sheet filed on 31 March 2025. It is based at Apollo Hospitals Complex Bhat, Ahmedabad, Gujarat, 382428.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100GJ2008FTC052859

  • Registration Number

    052859

  • Incorporation Date

    08 February 2008

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.98 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.98 M
  • Company Age 18 Year, 24 Days
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 52.36%
  • Profit Growth **** 11.48%
  • Ebitda **** 20.44%
  • Net Worth -25.43%
  • Total Assets -9.43%
Company report

Stemcyte India Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Stemcyte India Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Stemcyte India Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Chandra Sekhar Chivukula Director 28 Oct 2021 Current
Amitabha Banerjee Director 08 Dec 2011 Current
Wise Young Director 27 Mar 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 04 Aug 2022 Past
Pramod Abcsdd Alternate Director 22 Feb 2022 Past
Pramod Abcsdd Director 22 Feb 2022 Past
Pramod Abcsdd Director 16 Mar 2011 Past
Pramod Abcsdd Alternate Director 01 Sep 2017 Past
Pramod Abcsdd Director 30 Sep 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Stemcyte India Therapeutics.

Stemcyte India Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.36% increase. The company also saw a substantial improvement in profitability, with a 11.48% increase in profit. The company's net worth observed a substantial decline by a decrease of 25.43%.

Stemcyte India Therapeutics revenue growth over time
Stemcyte India Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 52.36%
*******
*******
*******
*******
Revenue from Operations
*******
 59.91%
*******
*******
*******
*******
Total Assets
*******
 -9.43%
*******
*******
*******
*******
Profit or Loss
*******
 11.48%
*******
*******
*******
*******
Net Worth
*******
 -25.43%
*******
*******
*******
*******
EBITDA
*******
 20.44%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Stemcyte India Therapeutics?

Unlock access to Stemcyte India Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Stemcyte India Therapeutics?

Unlock and access historical data on people associated with Stemcyte India Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Stemcyte India Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stemcyte India Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Stemcyte India Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    The activity Stemcyte India Therapeutics Private Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Stemcyte India Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Director Appointment

    The activity Chandra Sekhar Chivukula was appointed as a Director was appointed as a Director on 28 Oct 2021 & has been associated with this company since 4 years 4 months . was completed.

  • Director Appointment

    Progress on Wise Young was appointed as a Director was appointed as a Director on 27 Mar 2014 & has been associated with this company since 11 years 11 months . was documented.

  • Director Appointment

    The activity Amitabha Banerjee was appointed as a Director was appointed as a Director on 08 Dec 2011 & has been associated with this company since 14 years 2 months . was completed.

  • Company Incorporation

    The activity Stemcyte India Therapeutics Private Limited was registered on 08 Feb 2008 with Roc Ahmedabad & aged 18 years 24 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Stemcyte India Therapeutics Private Limited?

The CIN of Stemcyte India Therapeutics Private Limited is U85100GJ2008FTC052859.

Where is Stemcyte India Therapeutics Private Limited headquartered?

Stemcyte India Therapeutics Private Limited is headquartered at Apollo Hospitals Complex Bhat, Ahmedabad, Gujarat, 382428.

When was Stemcyte India Therapeutics Private Limited incorporated?

Stemcyte India Therapeutics Private Limited was incorporated on 08 February 2008.

Who are the current directors of Stemcyte India Therapeutics Private Limited?

The current directors of Stemcyte India Therapeutics Private Limited are

What is the primary industry of Stemcyte India Therapeutics Private Limited?

The primary industry of Stemcyte India Therapeutics Private Limited is Hospital And Medical Care.

Is Stemcyte India Therapeutics Private Limited a listed company?

Stemcyte India Therapeutics Private Limited is unlisted.

What is the capital structure of Stemcyte India Therapeutics Private Limited?

The authorized capital of Stemcyte India Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.98 M.

What is the compliance status of Stemcyte India Therapeutics Private Limited?

The compliance status of Stemcyte India Therapeutics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available